The Lancet Microbe
LightNews LightNews
banner
lancetmicrobe.bsky.social
The Lancet Microbe
@lancetmicrobe.bsky.social
1.3K followers 20 following 130 posts
The Lancet Microbe is an #OpenAccess journal publishing innovative and practice-changing research and opinion in clinical #microbiology

🌐 thelancet.com/journals/lanmic/home
Posts Replies Media Videos
Pinned
lancetmicrobe.bsky.social
The Lancet Microbe @lancetmicrobe.bsky.social · 2d
Our November issue is now online:

www.thelancet.com/journals/lan...

Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #HTLV-1 #AMR #Lassa #Neisseria #gonorrhoea #tuberculosis #TB #influenza

#IDSky #ClinMicro #OA
Cover of the November issue of The Lancet Microbe
Reposted by The Lancet Microbe
pasteurbangui.bsky.social
Exciting @thelancet.com podcast: Genomic surveillance of #Mpox in Central African Republic. With Dr Christian Noël Malaka, Dr Livia Patrono & Rebecca Barksby (@lancetmicrobe.bsky.social).

Listen: podcasts.apple.com/gb/podcast/c...

Article: www.thelancet.com/journals/lan...
November 8, 2025 at 6:55 AM
Reposted by The Lancet Microbe
annevdb.bsky.social
I'm delighted to share our latest publication in The Lancet Microbe on the development of a predictive biomarker for Adult T-cell leukemia (ATL) an aggressive malignancy induced by human T-cell leukemia virus (HTLV-1).
www.thelancet.com/journals/lan...

@lancetmicrobe.bsky.social
November 8, 2025 at 8:38 PM
lancetmicrobe.bsky.social
Our November issue is now online:

www.thelancet.com/journals/lan...

Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #HTLV-1 #AMR #Lassa #Neisseria #gonorrhoea #tuberculosis #TB #influenza

#IDSky #ClinMicro #OA
Cover of the November issue of The Lancet Microbe
November 8, 2025 at 9:38 PM
lancetmicrobe.bsky.social
New review article

P2Y12 inhibitors in #Staphylococcus aureus #bacteraemia: current evidence and clinical implications

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #bacteremia #OpenAccess #OA
October 31, 2025 at 9:22 AM
Reposted by The Lancet Microbe
thelancetinfdis.bsky.social
New Research

Oral itraconazole versus oral voriconazole for treatment-naive patients with chronic pulmonary aspergillosis in India (VICTOR-CPA trial): a single-centre, open-label, randomised, controlled, superiority trial

www.thelancet.com/journals/lan...
Oral itraconazole versus oral voriconazole for treatment-naive patients with chronic pulmonary aspergillosis in India (VICTOR-CPA trial): a single-centre, open-label, randomised, controlled, superiori...
Voriconazole was not superior to itraconazole for treating chronic pulmonary aspergillosis and was associated with a significantly higher incidence of adverse events. Our findings support the continue...
www.thelancet.com
October 30, 2025 at 9:53 AM
Reposted by The Lancet Microbe
richardsalvato.bsky.social
Together with @katwalter.bsky.social, we recently published in @lancetrh-americ.bsky.social a piece highlighting the urgent need for coordinated genomic surveillance of tuberculosis as the situation worsens across the Americas. www.thelancet.com/journals/lan...
Tuberculosis in the Americas: a worsening crisis amid genomic surveillance gaps
In 2023, tuberculosis (TB) returned as the leading infectious disease killer, after falling behind COVID-19 during the pandemic. An estimated 1.25 million lives were lost and 8.2 million new TB cases ...
www.thelancet.com
October 23, 2025 at 3:31 PM
Reposted by The Lancet Microbe
eclinicalmed.bsky.social
Derivation and external validation of community-acquired #pneumonia subphenotypes in Southeast Asia: a secondary analysis of prospective cohort studies

These subphenotypes may represent unique targets for future #CAP interventional trials

www.thelancet.com/journals/ecl...
#MedSky
October 29, 2025 at 12:08 PM
lancetmicrobe.bsky.social
New research article

Effect of decreasing the frequency of screening for #Neisseria gonorrhoeae and #Chlamydia trachomatis on the incidence of these infections and antimicrobial use among men who have sex with men using #HIV #PrEP in Belgium

www.thelancet.com/journals/lan...

#AMR #OpenAccess #OA
October 29, 2025 at 9:46 AM
Reposted by The Lancet Microbe
thelancet.com
How does research drive real change?

Our new Lancet- @elsfoundation.bsky.social Evidence to Impact Award is open for proposals!

If your project champions implementation science, health equity, and community engagement, apply now: tinyurl.com/j5dty567
Promotional card for the Lancet-Elsevier Foundation Evidence to Impact Award. Images depict two healthcare workers looking at a clipboard and a person facing into the sun with their eyes closed and holding their hand on their chest.
October 27, 2025 at 2:54 PM
Reposted by The Lancet Microbe
thelancet.com
📅 Save the date!

What can the world learn from Africa’s fight against HIV? Find out at this year’s @acmedsci.bsky.social & The Lancet International Health Lecture, delivered by Professor Quarraisha Abdool Karim.

🔗 Register now to attend in person or online on Nov 4: hubs.li/Q03H1YKY0
The International Health Lecture 2025. Copyright: The Academy of Medical Sciences.
October 28, 2025 at 8:45 AM
lancetmicrobe.bsky.social
In advance of our November issue, our latest editorial is now online

The next decade in #AMR: getting the basics right

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #OpenAccess #OA
October 27, 2025 at 10:25 AM
Reposted by The Lancet Microbe
thelancetinfdis.bsky.social
New Personal View

Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development

www.thelancet.com/journals/lan...
Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development
The rapid emergence of resistance to novel tuberculosis drugs, such as bedaquiline, is a key threat to the long-term effectiveness of novel regimens. Given that the introduction of these agents has en...
www.thelancet.com
October 26, 2025 at 12:31 PM
lancetmicrobe.bsky.social
New research article

New Delhi metallo-β-lactamase-producing #Acinetobacter baumannii in the USA from October, 2013, to March, 2022: a retrospective molecular epidemiological analysis

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #AMR #CRAB #NDM #OpenAccess #OA
October 24, 2025 at 8:33 AM
lancetmicrobe.bsky.social
New research article

Evaluation of antigen and antibody assays for surveillance of #Lassa virus in peri-domestic rodents in southeastern Sierra Leone: a cross-sectional study

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #ViroSky #OpenAccess #OA
October 24, 2025 at 8:30 AM
Reposted by The Lancet Microbe
thelancetinfdis.bsky.social
Read our November issue!

Featuring testing olorofim to treat fungal infections, introduction of nirsevimab for RSV in Chile, and new oxazolidinones for tuberculosis therapy.

www.thelancet.com/issue/S1473-...
October 23, 2025 at 8:55 AM
lancetmicrobe.bsky.social
New personal view article

Fluorescent acid-fast stains for diagnosing mycobacteria and beyond: back to the future?

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #Mycobacterium #tuberculosis #TB #OpenAccess #OA
October 21, 2025 at 8:20 PM
Reposted by The Lancet Microbe
lancetmicrobe.bsky.social
New personal view article

Whom #tuberculosis tests detect and why it matters: implications for diagnostic algorithms

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #TB #OpenAccess #OA
October 17, 2025 at 8:21 PM
lancetmicrobe.bsky.social
New research article

Evaluating 12 automated, whole-genome sequencing analysis pipelines for #Mycobacterium #tuberculosis complex: a comparative study

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #TB #WGS #OpenAccess #OA
October 21, 2025 at 8:20 AM
Reposted by The Lancet Microbe
thelancet.com
Community-acquired pneumonia is the leading infectious cause of morbidity and mortality globally.

Yet, there are several challenges associated with diagnosis, treatment, and long-term management of Community-acquired pneumonia.

Find out more in a new Seminar: tinyurl.com/hd2fwz7n
Figure showing the considerations for diagnosis and treatment initiation of patients with community-acquired pneumonia. Copyright: 2025 Elsevier Ltd. All rights are reserved.
October 20, 2025 at 2:47 PM
lancetmicrobe.bsky.social
New personal view article

Whom #tuberculosis tests detect and why it matters: implications for diagnostic algorithms

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #TB #OpenAccess #OA
October 17, 2025 at 8:21 PM
lancetmicrobe.bsky.social
New research article

Inferring the sensitivity of wastewater metagenomic sequencing for early detection of viruses: a statistical modelling study

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #ViroSky #OpenAccess #OA
October 14, 2025 at 2:50 PM
Reposted by The Lancet Microbe
jgreenanbarrett.bsky.social
Check out our new paper in @lancetmicrobe.bsky.social

In this IPD-MA we show that single-gene transcripts are equivalent to multi-gene signatures to Dx subclinical TB

They perform consistently across settings + show potential clinical utility to stratify therapy

#IDsky #TBsky

bit.ly/47jU7GN
Single-gene transcripts for subclinical tuberculosis: an individual participant data meta-analysis
Single-gene transcripts are equivalent to multi-gene signatures for detection of subclinical tuberculosis, with consistent performance across settings. Single-gene transcripts show potential clinical ...
bit.ly
October 14, 2025 at 11:31 AM
Reposted by The Lancet Microbe
lancetrh-americ.bsky.social
The October 2025 issue of The Lancet Regional Health - Americas is now available online: lnkd.in/gn2YTxQW
In this issue, we covered #Malaria; #ColorectalCancer; #ChagasDisease; #CognitiveHealth; #TobaccoPolicy; #SickleCell; #ObesityDiagnosis; #HealthCareResilience; and much more.
October 13, 2025 at 4:06 PM
Reposted by The Lancet Microbe
thelancetinfdis.bsky.social
📅 @phoebedownes.bsky.social will be attending ID Week, #IDWeek (19-22 October) in Atlanta, GA on behalf of The Lancet Infectious Diseases!

📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
October 13, 2025 at 11:26 AM